Viridian Therapeutics, Inc./DE Increase (Decrease) in Accounts Receivable
Viridian Therapeutics, Inc./DE (VRDN) reported Increase (Decrease) in Accounts Receivable of -$99.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2021-03-26
- Viridian Therapeutics, Inc./DE increase (decrease) in accounts receivable for the quarter ending 2020-12-31 was -$48.00K.
- Viridian Therapeutics, Inc./DE increase (decrease) in accounts receivable for the quarter ending 2020-09-30 was -$191.00K, a 129.20% decline year-over-year.
- Viridian Therapeutics, Inc./DE increase (decrease) in accounts receivable for the quarter ending 2020-06-30 was $244.00K, a 23.51% decline year-over-year.
- Viridian Therapeutics, Inc./DE increase (decrease) in accounts receivable for the quarter ending 2020-03-31 was -$104.00K.
- Viridian Therapeutics, Inc./DE increase (decrease) in accounts receivable for fiscal 2020 was -$99.00K, a 217.86% decline from fiscal 2019.
- Viridian Therapeutics, Inc./DE increase (decrease) in accounts receivable for fiscal 2019 was $84.00K.
- Viridian Therapeutics, Inc./DE increase (decrease) in accounts receivable for fiscal 2018 was -$1.43M, a 199.72% decline from fiscal 2017.
- Viridian Therapeutics, Inc./DE increase (decrease) in accounts receivable for fiscal 2017 was $1.44M, a 7080.00% increase from fiscal 2016.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | -$48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | -$239.00K derived: sum of 2 quarters · filed 2021-03-26 | $5.00K derived: sum of 3 quarters · filed 2021-03-26 | -$99.00K 10-K · filed 2021-03-26 | ||||
| 2020-09-30 | -$191.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $53.00K derived: sum of 2 quarters · filed 2020-11-12 | -$51.00K 10-Q · filed 2020-11-12 | -$922.00K derived: sum of 4 quarters · filed 2021-03-26 | ||||
| 2020-06-30 | $244.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $140.00K 10-Q · filed 2020-08-05 | -$731.00K derived: sum of 3 quarters · filed 2021-03-26 | -$77.00K derived: sum of 4 quarters · filed 2021-03-26 | ||||
| 2020-03-31 | -$104.00K 10-Q · filed 2020-05-08 | -$975.00K derived: sum of 2 quarters · filed 2021-03-26 | -$321.00K derived: sum of 3 quarters · filed 2021-03-26 | -$2.00K derived: sum of 4 quarters · filed 2021-03-26 | ||||
| 2019-12-31 | -$871.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | -$217.00K derived: sum of 2 quarters · filed 2021-03-26 | $102.00K derived: sum of 3 quarters · filed 2021-03-26 | $84.00K 10-K · filed 2021-03-26 | ||||
| 2019-09-30 | $654.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $973.00K derived: sum of 2 quarters · filed 2020-11-12 | $955.00K 10-Q · filed 2020-11-12 | -$403.00K derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $319.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $301.00K 10-Q · filed 2020-08-05 | -$1.06M derived: sum of 3 quarters · filed 2020-08-05 | -$873.00K derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-03-31 | -$18.00K 10-Q · filed 2020-05-08 | -$1.38M derived: sum of 2 quarters · filed 2020-05-08 | -$1.19M derived: sum of 3 quarters · filed 2020-05-08 | -$4.80M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | -$1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$1.17M derived: sum of 2 quarters · filed 2020-03-13 | -$4.79M derived: sum of 3 quarters · filed 2020-03-13 | -$1.43M 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | $184.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$3.43M derived: sum of 2 quarters · filed 2019-11-08 | -$74.00K 10-Q · filed 2019-11-08 | $747.00K derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | -$3.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$258.00K 10-Q · filed 2019-08-08 | $563.00K derived: sum of 3 quarters · filed 2019-08-08 | $659.00K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $3.35M 10-Q · filed 2019-05-09 | $4.17M derived: sum of 2 quarters · filed 2019-05-09 | $4.27M derived: sum of 3 quarters · filed 2019-05-09 | $4.53M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $821.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $917.00K derived: sum of 2 quarters · filed 2019-03-14 | $1.18M derived: sum of 3 quarters · filed 2019-03-14 | $1.44M 10-K · filed 2019-03-14 | ||||
| 2017-09-30 | $96.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $358.00K derived: sum of 2 quarters · filed 2018-11-07 | $615.00K 10-Q · filed 2018-11-07 | $626.00K derived: sum of 4 quarters · filed 2018-11-07 | ||||
| 2017-06-30 | $262.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $519.00K 10-Q · filed 2018-08-08 | $530.00K derived: sum of 3 quarters · filed 2018-08-08 | -$199.00K derived: sum of 4 quarters · filed 2018-08-08 | ||||
| 2017-03-31 | $257.00K 10-Q · filed 2018-05-09 | $268.00K derived: sum of 2 quarters · filed 2018-05-09 | -$461.00K derived: sum of 3 quarters · filed 2018-05-09 | $337.00K derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2016-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$718.00K derived: sum of 2 quarters · filed 2018-03-15 | $80.00K derived: sum of 3 quarters · filed 2018-03-15 | $20.00K 10-K · filed 2018-03-15 | $130.00K 10-K · filed 2017-03-24 | |||
| 2016-09-30 | -$729.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $69.00K derived: sum of 2 quarters · filed 2017-11-09 | $9.00K 10-Q · filed 2017-11-09 | $339.00K 10-Q · filed 2016-10-26 | -$144.00K derived: sum of 4 quarters · filed 2017-11-09 | |||
| 2016-06-30 | $798.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $738.00K 10-Q · filed 2017-08-11 | $264.00K 10-Q · filed 2016-08-15 | $585.00K derived: sum of 3 quarters · filed 2017-08-11 | $551.00K derived: sum of 4 quarters · filed 2017-08-11 | |||
| 2016-03-31 | -$60.00K 10-Q · filed 2017-05-11 | $96.00K 10-Q · filed 2016-05-16 | -$213.00K derived: sum of 2 quarters · filed 2017-05-11 | -$247.00K derived: sum of 3 quarters · filed 2017-05-11 | -$264.00K derived: sum of 4 quarters · filed 2017-05-11 | |||
| 2015-12-31 | -$153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | -$187.00K derived: sum of 2 quarters · filed 2017-03-24 | -$204.00K derived: sum of 3 quarters · filed 2017-03-24 | -$694.00K 10-K · filed 2017-03-24 | ||||
| 2015-09-30 | -$34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | -$51.00K derived: sum of 2 quarters · filed 2016-10-26 | -$541.00K 10-Q · filed 2016-10-26 | -$1.00M derived: sum of 4 quarters · filed 2016-10-26 | ||||
| 2015-06-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$507.00K 10-Q · filed 2016-08-15 | -$969.00K derived: sum of 3 quarters · filed 2016-08-15 | -$778.00K derived: sum of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | -$490.00K 10-Q · filed 2016-05-16 | -$952.00K derived: sum of 2 quarters · filed 2016-05-16 | -$761.00K derived: sum of 3 quarters · filed 2016-05-16 | -$576.00K derived: sum of 4 quarters · filed 2016-05-16 | ||||
| 2014-12-31 | -$462.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-21 | -$271.00K derived: sum of 2 quarters · filed 2016-03-21 | -$86.00K derived: sum of 3 quarters · filed 2016-03-21 | $94.00K 10-K · filed 2016-03-21 | $271.00K 10-K · filed 2015-03-27 | |||
| 2014-09-30 | $191.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $376.00K derived: sum of 2 quarters · filed 2015-11-13 | $556.00K 10-Q · filed 2015-11-13 | $700.48K 10-Q · filed 2014-11-14 | $624.27K derived: sum of 4 quarters · filed 2015-11-13 | |||
| 2014-06-30 | $185.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $365.00K 10-Q · filed 2015-08-14 | $365.39K 10-Q · filed 2014-08-14 | $433.27K derived: sum of 3 quarters · filed 2015-08-14 | $228.66K derived: sum of 4 quarters · filed 2015-08-14 | |||
| 2014-03-31 | $180.00K 10-Q · filed 2015-05-15 | $248.27K derived: sum of 2 quarters · filed 2015-05-15 | $43.66K derived: sum of 3 quarters · filed 2015-05-15 | |||||
| 2013-12-31 | $68.27K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | -$136.34K derived: sum of 2 quarters · filed 2015-03-27 | -$202.00K 10-K · filed 2015-03-27 | |||||
| 2013-09-30 | -$204.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$270.27K 10-Q · filed 2014-11-14 | ||||||
| 2013-06-30 | -$65.66K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |